Advertisement
Screener

TELADOC HEALTH, INC. (TDOC) Overview

TELADOC HEALTH, INC. (TDOC) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual -0.21; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual -0.36; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual -0.28; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual -0.19; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$4.25$5.06$6.03$7.19$8.56$10.212025-11-062026-11-06$4.25$8.70$17.84$36.56$74.92$153.552021-11-082026-11-06$4.25$10.01$23.60$55.64$131.18$309.272016-11-072026-11-06$4.25$10.01$23.60$55.64$131.18$309.272015-06-302026-11-06$4.25$10.01$23.60$55.64$131.18$309.272015-06-302026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$8.75
Previous close
$5.75
Change
$3.00
Change (%)
52.17%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

TDOC
-17.86%
S&P 500
(m)

1 year

TDOC
-29.88%
S&P 500
(m)

3 years

TDOC
-69.07%
S&P 500
(m)

5 years

TDOC
-95.43%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual -0.21

-0.61-0.46-0.31-0.16-0.0131 Mar 2025: estimate (m); actual -0.5331 Mar 2025(m)30 Jun 2025: estimate (m); actual -0.1930 Jun 2025(m)30 Sept 2025: estimate (m); actual -0.2830 Sept 2025(m)31 Mar 2026: estimate (m); actual -0.3631 Mar 2026(m)30 Jun 2026: estimate (m); actual -0.2130 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)-0.21(m)(m)
1 Jan 202631 Mar 2026(m)-0.36(m)(m)
1 Jul 202530 Sept 2025(m)-0.28(m)(m)
1 Apr 202530 Jun 2025(m)-0.19(m)(m)
1 Jan 202531 Mar 2025(m)-0.53(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual -1.14

-84.68-63.75-42.82-21.89-0.9631 Dec 2021: estimate (m); actual -2.7331 Dec 2021(m)31 Dec 2022: estimate (m); actual -84.6031 Dec 2022(m)31 Dec 2023: estimate (m); actual -1.3431 Dec 2023(m)31 Dec 2024: estimate (m); actual -5.8731 Dec 2024(m)31 Dec 2025: estimate (m); actual -1.1431 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)-1.14(m)(m)
1 Jan 202431 Dec 2024(m)-5.87(m)(m)
1 Jan 202331 Dec 2023(m)-1.34(m)(m)
1 Jan 202231 Dec 2022(m)-84.60(m)(m)
1 Jan 202131 Dec 2021(m)-2.73(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 606.93M ■ Earnings -38.91M — Profit margin -6.41%

-148.57M-11.4%143.29M-8.6%435.14M-5.7%727.00M-2.9%30 Sept 2025: revenue 626.44M; earnings -49.51M; profit margin -7.90%30 Sept 202531 Dec 2025: revenue 642.27M*; earnings -25.14M*; profit margin -3.91%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2025-10-01 to 2025-12-31; USD.31 Dec 202531 Mar 2026: revenue 613.85M; earnings -63.84M; profit margin -10.40%31 Mar 202630 Jun 2026: revenue 606.93M; earnings -38.91M; profit margin -6.41%30 Jun 2026

31 Dec 2025 ■ Revenue 2.53B ■ Earnings -0.20B — Profit margin -7.92%

-15.61B-568.5%-8.89B-381.3%-2.17B-194.1%4.55B-6.9%31 Dec 2022: revenue 2.41B; earnings -13.66B; profit margin -567.53%31 Dec 202231 Dec 2023: revenue 2.60B; earnings -0.22B; profit margin -8.47%31 Dec 202331 Dec 2024: revenue 2.57B; earnings -1.00B; profit margin -38.97%31 Dec 202431 Dec 2025: revenue 2.53B; earnings -0.20B; profit margin -7.92%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$8.75(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$8.75High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning TDOC

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$-177.40M
Profit margin
-7.13%
Return on assets · 12 month
-6.28%
Index membership
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
3.31M
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
-9.45%*
Total return · month
-11.54%*
Total return · quarter
-33.83%*
Total return · half year
11.87%*
Total return · year to date
-17.86%*
Total return · 1 year
-29.88%*
Total return · 3 years
-69.07%*
Total return · 5 years
-95.43%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$2.49B
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

TELADOC HEALTH, INC. Overview

View more →

(m)

(m)

SEC CIK
1477449
Industry (SIC)
8011 Services-Offices & Clinics of Doctors of Medicine
Country of operation
United States
Business address
155 E 44TH STREET, SUITE 1700, NEW YORK, New York, 10017, United States
Fiscal year end
1231
Phone
2036352002

Similar stocks

Stock NameCountryMarket CapPE Ratio
SBC Medical Group Holdings Inc (SBC)United States$0.487B
Airsculpt Technologies, Inc. (AIRS)United States$0.146B-27.36
LifeMD, Inc. (LFMD)United States$0.141B982.53